During the past decade, CHU de Limoges - Fédération Hépatologie conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 3 clinical trials were completed, i.e. on average, 75% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 3 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "CHU de Limoges - Fédération Hépatologie" are "Nonalcoholic Steatohepatitis" (2 trials), "Amyloidosis" (1 trials), "Hepatitis B" (1 trials), "Renal Failure With Tubular Necrosis" (1 trials) and "Smoldering Multiple Myeloma" (1 trials). Many other conditions were trialed in "CHU de Limoges - Fédération Hépatologie" in a lesser frequency.

Most popular intervention types in "CHU de Limoges - Fédération Hépatologie" are "Drug" (4 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo to match SEL 18 mg" (2 trials), "Placebo to match SEL 6 mg" (2 trials), "SEL" (2 trials), "Bortezomib" (1 trials) and "Cyclophosphamide" (1 trials). Other intervention names were less common.

The vast majority of trials in "CHU de Limoges - Fédération Hépatologie" are 5 trials for "All" genders.

Currently, there are NaN active trials in "CHU de Limoges - Fédération Hépatologie". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in CHU de Limoges - Fédération Hépatologie, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in CHU de Limoges - Fédération Hépatologie, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".